ADR North America, ISM announce Asian Training Partnership

Ann Arbor, Mi.—ADR North America and Institute for Supply Management (ISM) have entered a partnership that dramatically expands training opportunities for supply management professionals throughout the Asia-Pacific region. Global supply management consultancy ADR North America, LLC and its existing training partner, ISM, have entered an agreement with Procurement and Sourcing Institute of Asia and TransProcure Corporation (PASIA/TransProcure), both based in Manila, Philippines. The partnered organizations will adhere to a consistent business strategy for responding to requests for proposals and other opportunities to deliver customized in-company training and web-based e-learning.

PASIA has gained global prominence as it has gained trained members from outside of its home country of the Philippines, throughout Asia and the Middle East. TransProcure, likewise, delivers solutions and services complementing PASIA’s programs. ISM and ADR North America combined resources more than two years ago to leverage exclusive resources and products, including ADR’s Development Needs Analysis (DNA) learning assessments and ISM’s Knowledge Center.

“Our partnership agreement formalizes the alignment of ISM and ADR’s training and assessment resources with PASIA/TransProcure’s educators and consultants,” says ISM CEO Paul Novak, CPSM, C.P.M., A.P.P., MCIPS. “All three partner organizations have a clear path and expanded outreach to future clients in Asia-Pacific and Arab/Gulf/United Arab Emirates countries.”

“PASIA maintains a strong and dynamic presence in this part of the world,” says Charlie Villaseñor, CEO – TransProcure and affiliate officer of PASIA. “This joint effort to establish consistent processes around the delivery of world-class material reinforces our goal of championing professionalism throughout the entire Asia-Pacific and Middle East and serving the profession better.”

For more information, visit www.ism.ws, www.adrna.com, www.pasia.org or www.transprocure.com.

Loading